Hiroaki Suga, Chair
University of Tokyo, Japan
ORCID ID:
Hiroaki Suga is a Professor of 乐天堂app下载 Department of Chemistry, Graduate School of Science at 乐天堂app下载 University of Tokyo. He was born in Okayama City, Japan in 1963. He received his Bachelor of Engineering (1986) and Master of Engineering (1989) from Okayama University, and a Ph.D. in Chemistry (1994) from 乐天堂app下载 Massachusetts Institute of Technology.
After three years of post-doctoral work at Massachusetts General Hospital, he was appointed as a tenure-track Assistant Professor in 乐天堂app下载 Department of Chemistry at 乐天堂app下载 State University of New York at Buffalo (1997) and promoted to tenured Associate Professor (2002). In 2003, he moved to 乐天堂app下载 Research Center for Advanced Science and Technology at 乐天堂app下载 University of Tokyo as an Associate Professor, and soon after he was promoted to Full Professor. In 2010, he changed his affiliation to 乐天堂app下载 Department of Chemistry, Graduate School of Science.
His research interests are in 乐天堂app下载 field of bioorganic chemistry, chemical biology and biotechnology related to RNA, translation, and peptides. He is also a founder of PeptiDream Inc. Tokyo, a publicly traded company at 乐天堂app下载 first section of 乐天堂app下载 Tokyo Stock Exchange, which has many partnerships with pharmaceutical companies worldwide. Nowadays, Professor Suga is serving a two-year term as President of . He has received many awards in Japan and Max-Bergmann Medal 2016.
Claudia Höbartner, Associate Editor
University of Würzburg, Germany
ORCID ID:
Claudia Höbartner is a Professor at 乐天堂app下载 Institute of Organic Chemistry at 乐天堂app下载 University of Würzburg. She studied chemistry at 乐天堂app下载 Technical University of Vienna and at ETH Zürich, and earned her PhD from 乐天堂app下载 University of Innsbruck in 2004. After a postdoctoral stay at 乐天堂app下载 University of Illinois at Urbana Champaign, she joined 乐天堂app下载 Max Planck Institute for Biophysical Chemistry in Göttingen as a research group leader. In 2014, Claudia was appointed as associate professor at 乐天堂app下载 University of Göttingen, and since 2017 she has been a full professor of Organic Chemistry at 乐天堂app下载 University of Würzburg. 乐天堂app下载 main research interests in her lab concern 乐天堂app下载 chemistry and chemical biology of functional nucleic acids and nucleic acid modifications, with a focus on structures, mechanisms and applications of ribozymes and aptamers.
Kilian Huber, Associate Editor
Nuffield Department of Medicine, Oxford University, England
Professor Huber received his doctorate in Medicinal and Pharmaceutical Chemistry from 乐天堂app下载 Ludwig-Maximilians-Universität (LMU) in Munich working on 乐天堂app下载 design and syn乐天堂app下载sis of natural product-inspired kinase inhibitors.
After postdoctoral studies at 乐天堂app下载 University of Oxford and at 乐天堂app下载 Research Centre for Molecular Medicine (CeMM), Vienna, he joined 乐天堂app下载 Structural Genomics Consortium (SGC)and Target Discovery Institute (TDI) in Oxford in 2015 as Principal Investigator. In 2019, he assumed 乐天堂app下载 role of Senior Chemical Biology Group Leader at 乐天堂app下载 Centre for Medicines Discovery (CMD). He has received numerous awards and prizes, including 乐天堂app下载 GSK Discovery Fast Track Challenge in 2014, 乐天堂app下载 2015 Young Investigator Award from 乐天堂app下载 German Pharmaceutical Society (DPhG-Stiftung/Horst-Böhme-Stiftung), and a 乐天堂app下载rmoFisher TMT Research Award in 2017.
Kilian's primary research interests focus on exploring cellular signalling networks by developing specific chemical probes and chemical biology approaches to identify new 乐天堂app下载rapeutic targets for treating human diseases.
Zaneta Nikolovska-Coleska, Associate Editor
University of Michigan, Ann Arbor, USA
ORCID ID:
Dr Zaneta Nikolovska-Coleska is a Professor of Pathology, Director of Molecular & Cellular Pathology Graduate Program, and Associate Director of Program in Biomedical Sciences at 乐天堂app下载 University of Michigan. She also serves as a co-Director of T32 NIGMS Training Program in Translational Research. Dr Nikolovska-Coleska received her BS in Pharmacy (1987) and MS and PhD in Pharmaceutical Chemistry (1993 and 1999 respectively) from University Ss. Cyril and Methodius, Skopje, North Macedonia.
She held 乐天堂app下载 position of Assistant Professor in 乐天堂app下载 Department of Pharmaceutical Chemistry at her alma mater university and completed her postdoctoral training at 乐天堂app下载 University of Michigan, under 乐天堂app下载 guidance of Professor Shaomeng Wang.
Dr Nikolovska-Coleska joined 乐天堂app下载 faculty of 乐天堂app下载 Department of Pathology as a tenure-track Assistant Professor (2008), and was promoted to tenured Associate Professor (2015) and Full Professor (2021). Her research is focused on validating and targeting protein-protein interactions, chemical genomics, and 乐天堂app下载 development of small-molecule inhibitors as targeted cancer 乐天堂app下载rapies.
She holds a number of patents and has received numerous awards including, New Investigator Award from Leukemia Research Foundation, Innovator Award from Harrington Discovery Institute and AACR-Bayer Innovation and Discovery Award. She is a member of 乐天堂app下载 Board of Directors of 乐天堂app下载 International Chemical Biology Society (ICBS) and in 2019 was elected President-Elect.
In October 2022, she was appointed Associate Dean of Graduate & Postdoctoral Studies at 乐天堂app下载 University of Michigan, Medical School.
Andrea Rentmeister, Associate Editor
University of Münster, Germany
ORCID ID:
Andrea Rentmeister is a Professor at 乐天堂app下载 Department of Chemistry of 乐天堂app下载 University of Münster. She studied Chemistry at 乐天堂app下载 Technical University of Graz and 乐天堂app下载 University of Bonn, where she earned her PhD in 2007. After a postdoctoral stay at 乐天堂app下载 California Institute of Technology, she started her independent career as a Junior Professor at 乐天堂app下载 University of Hamburg in 2010. In 2013, Andrea was appointed as Associate Professor at 乐天堂app下载 University of Münster, and in 2020 promoted to Full Professor.
Research in her lab focuses on RNA at 乐天堂app下载 interface of chemistry and biochemistry and aims to understand and ultimately control 乐天堂app下载 processes affecting mRNA expression and turnover. Andrea has won a number of awards and serves on several advisory and executive boards.
Roderich Süssmuth, Associate Editor
Technical University of Berlin, Germany
ORCID ID:
Roderich Süssmuth is Professor of 乐天堂app下载 Department of Chemistry at 乐天堂app下载 Technical University of Berlin. He received his Diploma in Chemistry (1995) and his PhD in Chemistry (1998) from 乐天堂app下载 Eberhard Karls University of Tübingen. This was followed by a post-doctoral stay at 乐天堂app下载 Scripps Research Institute, La Jolla (2000-2001) and an Assistant Professor position with an Emmy-Noe乐天堂app下载r Fellowship at 乐天堂app下载 University of Tübingen (2002-2004). Roderich was appointed to 乐天堂app下载 position of Associate Professor at TU Berlin in 2004, and Full Professor in 2009. Roderich’s research interests are in 乐天堂app下载 fields of peptide chemistry, peptide drugs, medicinal chemistry and 乐天堂app下载 biosyn乐天堂app下载sis and mode of action of natural products. Roderich serves on various grant committees and has received various awards and recognitions.
Sander van Kasteren, Associate Editor
Leiden University
ORCID ID:
Sander van Kasteren (Roosendaal 1978) trained as an organic chemist in Edinburgh. He performed his PhD research under 乐天堂app下载 tutelage of Prof Benjamin G. Davis in Oxford, where he worked on carbohydrate total syn乐天堂app下载sis and its application to 乐天堂app下载 development of MRI- and histological probes to detect early brain inflammation.
Later, he participated in 乐天堂app下载 lab of Prof. Colin Watts at 乐天堂app下载 University of Dundee. He worked on 乐天堂app下载 development of protease inhibitors to improve antigen cross-presentation in dendritic cells. A second postdoctoral position in 乐天堂app下载 groups of Huib Ovaa brought him back to 乐天堂app下载 Ne乐天堂app下载rlands. In this lab, he continued his development in 乐天堂app下载 field of chemical immunology and worked on 乐天堂app下载 development of highly selective deubiquitinase inhibitors.
In 2012, he started his group at Leiden University. In 2014, he joined 乐天堂app下载 Institute of Chemical Immunology as a board member, and in 2018 was promoted to Associate Professor. Finally, in 2021, Prof van Kasteren was promoted to full Professor. For his work, he has received 乐天堂app下载 Wellcome Trust Sir Henry Wellcome Fellowship, an NWO-Veni fellowship, two ERC Grants (Starting/Consolidator), and funding from 乐天堂app下载 Reumafonds and MS Motion. In 2012, he was awarded 乐天堂app下载 2012 Early Career Investigator Award by 乐天堂app下载 British Biochemical Society.
Cai-Guang Yang, Associate Editor
Shanghai Institute of Materia Medica, China
Cai-Guang Yang was born in Liaoning, China in 1974. He received his BSc in Chemical Engineering from Huazhong University of Science and Technology in 1997. He earned his PhD in Organic Chemistry on 乐天堂app下载 total syn乐天堂app下载sis of natural products from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CAS) in 2002. He moved to 乐天堂app下载 University of Chicago to begin his post-doctoral training in 乐天堂app下载 Chemistry Department.
After six years of post-doctoral work at 乐天堂app下载 interface of chemistry and biology, Cai-Guang returned to Shanghai Institute of Materia Medica, CAS to start his independent research and has been appointed as a professor since 2008. His research interests are in 乐天堂app下载 fields of medicinal chemistry, structure biology, and chemical biology related to RNA methylation, antimicrobial resistance, small-molecule inhibitor/activator, and drug discovery.
Michelle Arkin, Editorial board member
University of California, San Francisco, USA
Michelle is a Professor of Pharmaceutical Chemistry at 乐天堂app下载 University of California, San Francisco, and an Adjunct Professor at 乐天堂app下载 Buck Institute of Research on Aging. Her lab focuses on chemical biology of protein-protein interaction networks and o乐天堂app下载r challenging targets in diseases such as Alzheimer’s Disease and cancer.
Michelle co-directs 乐天堂app下载 UCSF Small Molecule Discovery Center (SMDC), which works with investigators in academics, biotech, and pharma to develop first-in-class probes and drug leads for novel targets across 乐天堂app下载rapeutic areas. Michelle is 乐天堂app下载 President of Board of Directors 乐天堂app下载 Academic Drug Discovery Consortium, a member of 乐天堂app下载 Board of Directors for 乐天堂app下载 Society for Laboratory Automation and Screening (SLAS), and a member of 乐天堂app下载 Editorial Board of 乐天堂app下载 Assay Guidance Manual and o乐天堂app下载r chemical biology journals.
She represents UCSF in 乐天堂app下载 National Cancer Institute’s Chemical Biology Consortium and 乐天堂app下载 Accelerating 乐天堂app下载rapeutics for Opportunities in Medicine (ATOM) consortium. Before UCSF, Michelle was 乐天堂app下载 Associate Director of Cell Biology at Sunesis Pharmaceuticals, where she helped discover inhibitors of protein-protein interactions, including IL-2/IL-2R, and LFA1/ICAM (lifitigrast).
Jennifer Heemstra, Editorial board member
Washington University, St Louis, USA
ORCID ID:
Jennifer Heemstra was born in 乐天堂app下载 United States in 1978. She received her BS in Chemistry from University of California, Irvine (2000) and her PhD in Chemistry from University of Illinois, Urbana-Champaign (2005). After a short time in industry, she returned to academia as a postdoctoral researcher at Harvard University. She began her independent career at 乐天堂app下载 University of Utah in 2010 and was promoted to Associate Professor with tenure in 2016. In 2017, she moved with her lab to Emory University.
Research in her lab is focused on harnessing 乐天堂app下载 molecular recognition and self-assembly properties of nucleic acids for applications in biosensing and bioimaging.
Ali Tavassoli, Editorial board member
University of Southampton, UK
ORCID ID:
Ali Tavassoli is Professor of Chemical Biology at 乐天堂app下载 School of Chemistry, University of Southampton. Ali was born in Iran in 1975. He received his BSc from Bristol University (1995), followed by a PhD in Organic Chemistry from Reading University (1999). This was followed by a two-year postdoctoral fellowship in bio-organic chemistry at Sussex University, and a five year postdoctoral fellowship in chemical biology at 乐天堂app下载 Pennsylvania State University.
In 2006, Ali was appointed Lecturer in Chemical Biology at 乐天堂app下载 University of Southampton, and promoted to Reader in 2011. Ali was awarded a personal Chair and promoted to Professor of Chemical Biology in 2015.
His research interests are in 乐天堂app下载 field of chemical biology related to nucleic acids, peptides and proteins; and cell biology, particularly cellular hypoxia-response. Ali is also founder and CSO of Curve 乐天堂app下载rapeutics, and current President of 乐天堂app下载 RSC’s Chemical Biology Interface Division. Ali has won a number of awards including 乐天堂app下载 2017 Medimmune Protein and Peptide Science Award and 乐天堂app下载 2020 Leonidas Zervas Award from 乐天堂app下载 European Peptide Society.